Trastuzumab cardiac side effects: Only time will tell

被引：14

作者：

Levine, MN ^{[1
]}

机构：

[1] Jurevinski Canc Ctr, Hamilton, ON, Canada

[2] McMaster Univ, Hamilton, ON, Canada

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 31期

关键词：

D O I：

10.1200/JCO.2005.04.1558

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：7775 / 7776

页数：2

共 10 条

[1] The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer [J].

Bull, SB ;

Ozcelik, H ;

Pinnaduwage, D ;

Blackstein, ME ;

Sutherland, DAJ ;

Pritchard, KI ;

Tzontcheva, AT ;

Sidlofsky, S ;

Hanna, WM ;

Qizilbash, AH ;

Tweeddale, ME ;

Fine, S ;

McCready, DR ;

Andrulis, IL .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) :86-96

[2] ErbB2 pathways in heart and neural diseases [J].

Garratt, AN ;

Özcelik, C ;

Birchmeier, C .

TRENDS IN CARDIOVASCULAR MEDICINE, 2003, 13 (02) :80-86

[3] Essential roles of Her2/erbB2 in cardiac development and function [J].

Negro, A ;

Brar, BK ;

Lee, KF .

RECENT PROGRESS IN HORMONE RESEARCH, VOL 59: CARDIOVASCULAR ENDOCRINOLOGY & OBESITY, 2004, 59 :1-12

[4]

PICCARTGEBHART MN, 2005, HERA TRIALS M ED VIR

[5] The use of radiotherapy after mastectomy: A review of the literature [J].

Pierce, LJ .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (08) :1706-1717

[6]

ROMOND E, 2005, JOINT ANAL NSABP B31

[7] Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. [J].

Slamon, DJ ;

Leyland-Jones, B ;

Shak, S ;

Fuchs, H ;

Paton, V ;

Bajamonde, A ;

Fleming, T ;

Eiermann, W ;

Wolter, J ;

Pegram, M ;

Baselga, J ;

Norton, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :783-792

[8] Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31 [J].

Tan-Chiu, E ;

Yothers, G ;

Romond, E ;

Geyer, CE ;

Ewer, M ;

Keefe, D ;

Shannon, RP ;

Swain, SM ;

Brown, A ;

Fehrenbacher, L ;

Vogel, VG ;

Seay, TE ;

Rastogi, P ;

Mamounas, EP ;

Wolmark, N ;

Bryant, J .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :7811-7819

[9] Prognostic factors affecting the natural history of node-negative breast cancer [J].

Trudeau, ME ;

Pritchard, KI ;

Chapman, JAW ;

Hanna, WM ;

Kahn, HJ ;

Murray, D ;

Sawka, CA ;

Mobbs, BG ;

Andrulis, I ;

McCready, DR ;

Lickley, HL .

BREAST CANCER RESEARCH AND TREATMENT, 2005, 89 (01) :35-45

[10] Neuregulin receptor ErbB2 localization at T-tubule in cardiac and skeletal muscle [J].

Ueda, H ;

Oikawa, A ;

Nakamura, A ;

Terasawa, F ;

Kawagishi, K ;

Moriizumi, T .

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2005, 53 (01) :87-91

← 1 →